# sources

title: ir.recursion.com: Recursion unveils lowe drug discovery software jp morgan
node_name: Recursion OS Phenomics Platform
created_at: 2026-04-20 20:52:09
url:
https://ir.recursion.com/news-releases/news-release-details/recursion-unveils-lowe-drug-discovery-software-jp-morgan


title: ir.recursion.com: Recursion reports fourth quarter and full year 2025 financial
node_name: Recursion OS Phenomics Platform
created_at: 2026-04-20 20:52:09
url:
https://ir.recursion.com/news-releases/news-release-details/recursion-reports-fourth-quarter-and-full-year-2025-financial


node_name: Multi-Cancer Early Detection Liquid Biopsy
created_at: 2026-04-20 20:52:09
url:
https://medcitynews.com/2026/02/grail-galleri-blood-test-multi-cancer-early-detection-mced-screening-liquid-biopsy-gral/

title:
medcitynews.com: Grail galleri blood test multi cancer early detection mced screening liquid biopsy gral


node_name: De Novo Protein Design via Diffusion
created_at: 2026-04-20 20:52:09
url:
https://www.pharmasalmanac.com/articles/reprogramming-the-rules-how-ai-is-transforming-de-novo-protein-design-in-drug-development

title:
pharmasalmanac.com: Reprogramming the rules how ai is transforming de novo protein design in drug development


node_name: Digital Twin Synthetic Control Arms
created_at: 2026-04-20 20:52:09
url:
https://www.pienomial.com/blog/digital-twins-in-clinical-trials-how-ai-generated-virtual-control-arms-are-rewriting-study-design-in-2026

title:
pienomial.com: Digital twins in clinical trials how ai generated virtual control arms are rewriting study design in 2026


title: ir.schrodinger.com: Default
node_name: Schrödinger FEP+ Physics-AI Hybrid
created_at: 2026-04-20 20:52:09
url:
https://ir.schrodinger.com/press-releases/news-details/2026/Schrdinger-Provides-Update-on-Progress-Across-the-Business-and-Outlines-2026-Strategic-Priorities/default.aspx


title: investors.tempus.com: Tempus introduces fuses program designed transform therapeutic
node_name: Tempus AI Multimodal Data Network
created_at: 2026-04-20 20:52:09
url:
https://investors.tempus.com/news-releases/news-release-details/tempus-introduces-fuses-program-designed-transform-therapeutic


title: fda.gov: Guiding principles good ai practice drug development
node_name: FDA AI Drug Development Framework
created_at: 2026-04-20 20:52:09
url:
https://www.fda.gov/about-fda/artificial-intelligence-drug-development/guiding-principles-good-ai-practice-drug-development


title: foley.com: Ai drug development fda releases draft guidance
node_name: FDA AI Drug Development Framework
created_at: 2026-04-20 20:52:09
url:
https://www.foley.com/insights/publications/2025/01/ai-drug-development-fda-releases-draft-guidance/


title: owkin.com: Federated learning scales real world data access for external control arms
node_name: Federated Learning Healthcare Data Moat
created_at: 2026-04-20 20:52:09
url:
https://www.owkin.com/blogs-case-studies/federated-learning-scales-real-world-data-access-for-external-control-arms


title: pathai.com: Pathai receives fda clearance for aisight dx platform for primary diagnosis
node_name: Digital Pathology AI Diagnostics
created_at: 2026-04-20 20:52:09
url:
https://www.pathai.com/resources/pathai-receives-fda-clearance-for-aisight-dx-platform-for-primary-diagnosis


node_name: Digital Pathology AI Diagnostics
created_at: 2026-04-20 20:52:09
url:
https://www.paige.ai/press-releases/us-fda-grants-paige-breakthrough-device-designation-for-ai-application-that-detects-cancer-across-different-anatomic-sites

title:
paige.ai: Us fda grants paige breakthrough device designation for ai application that detects cancer across different anatomic sites


node_name: AI Drug Discovery Clinical Translation Gap
created_at: 2026-04-20 20:52:09
url:
https://fortune.com/2025/09/12/the-ai-drug-breakthrough-is-taking-a-long-time-to-arrive-for-reasons-that-may-have-little-to-do-with-the-technologys-limits/

title:
fortune.com: The ai drug breakthrough is taking a long time to arrive for reasons that may have little to do with the technologys limits


title: biopharmadive.com: 723714
node_name: AI Drug Discovery Clinical Translation Gap
created_at: 2026-04-20 20:52:09
url:
https://www.biopharmadive.com/news/recursion-exscientia-merger-deal-artificial-intelligence-drug-discovery/723714/


node_name: Virtual Cell Foundation Models
created_at: 2026-04-20 20:52:09
url:
https://www.recursion.com/news/since-its-inception-recursion-has-been-building-the-foundation-for-the-first-virtual-cell

title:
recursion.com: Since its inception recursion has been building the foundation for the first virtual cell


title: synbiobeta.com: Evolutionaryscale raises 142m and unveils ai model esm3 to transform biology
node_name: ESM3 Protein Language Model
created_at: 2026-04-20 20:52:09
url:
https://www.synbiobeta.com/read/evolutionaryscale-raises-142m-and-unveils-ai-model-esm3-to-transform-biology


title: ddw-online.com: How the next generation of ai is reshaping antibody drug discovery 39920 202601
node_name: AI Antibody Closed-Loop Discovery
created_at: 2026-04-20 20:52:09
url:
https://www.ddw-online.com/how-the-next-generation-of-ai-is-reshaping-antibody-drug-discovery-39920-202601/


node_name: AI Antibody Closed-Loop Discovery
created_at: 2026-04-20 20:52:09
url:
https://labcritics.com/blog/2026/04/15/amazon-bio-discovery-latest-entrant-aiming-to-rewire-the-antibody-discovery-pipeline/

title:
labcritics.com: Amazon bio discovery latest entrant aiming to rewire the antibody discovery pipeline


title: clinicaltrialvanguard.com: The wearable gap why sensors are outrunning the trials that use them
node_name: Decentralized Trials Digital Biomarker Gap
created_at: 2026-04-20 20:52:09
url:
https://www.clinicaltrialvanguard.com/article/trend-watch/the-wearable-gap-why-sensors-are-outrunning-the-trials-that-use-them/


title: fda.gov: Cder emerging drug safety technology program edstp
node_name: AI Pharmacovigilance Signal Detection
created_at: 2026-04-20 20:52:09
url:
https://www.fda.gov/drugs/science-and-research-drugs/cder-emerging-drug-safety-technology-program-edstp


title: morganlewis.com: Awash in data fda removes a barrier in real world evidence generation
node_name: AI Real-World Evidence Regulatory Revolution
created_at: 2026-04-20 20:52:09
url:
https://www.morganlewis.com/blogs/asprescribed/2026/01/awash-in-data-fda-removes-a-barrier-in-real-world-evidence-generation


title: orrick.com: FDA Removes Significant Barrier to Using Real World Evidence in Product Submissions
node_name: AI Real-World Evidence Regulatory Revolution
created_at: 2026-04-20 20:52:09
url:
https://www.orrick.com/en/Insights/2025/12/FDA-Removes-Significant-Barrier-to-Using-Real-World-Evidence-in-Product-Submissions


node_name: Rentosertib Phase 2a Clinical Proof Point
created_at: 2026-04-20 20:52:09
url:
https://www.drugdiscoverytrends.com/insilicos-ai-designed-rentosertib-shows-promise-in-first-phase-2a-trial-results/

title:
drugdiscoverytrends.com: Insilicos ai designed rentosertib shows promise in first phase 2a trial results


title: cen.acs.org
node_name: Nobel Prize Chemistry 2024 AI Validation Event
created_at: 2026-04-20 20:52:09
url:
https://cen.acs.org/people/nobel-prize/Baker-Hassabis-and-Jumper-win-2024-Nobel-Prize-in-Chemistry/102/web/2024/10


title: fiercebiotech.com: Xaira exec divulges rd focus how ai company chasing what industry hungriest
node_name: Xaira Therapeutics AI-First Drug Company
created_at: 2026-04-20 20:52:09
url:
https://www.fiercebiotech.com/biotech/xaira-exec-divulges-rd-focus-how-ai-company-chasing-what-industry-hungriest


node_name: NVIDIA BioNeMo Biological AI Infrastructure
created_at: 2026-04-20 20:52:09
url:
https://nvidianews.nvidia.com/news/nvidia-bionemo-platform-adopted-by-life-sciences-leaders-to-accelerate-ai-driven-drug-discovery

title:
nvidianews.nvidia.com: Nvidia bionemo platform adopted by life sciences leaders to accelerate ai driven drug discovery


node_name: NVIDIA BioNeMo Biological AI Infrastructure
created_at: 2026-04-20 20:52:09
url:
https://nvidianews.nvidia.com/news/nvidia-and-lilly-announce-co-innovation-lab-to-reinvent-drug-discovery-in-the-age-of-ai

title:
nvidianews.nvidia.com: Nvidia and lilly announce co innovation lab to reinvent drug discovery in the age of ai


title: genengnews.com: Arc institutes ai model designs the genetic code across all domains of life
node_name: Evo2 Genomic Foundation Model
created_at: 2026-04-20 20:52:09
url:
https://www.genengnews.com/gen-edge/arc-institutes-ai-model-designs-the-genetic-code-across-all-domains-of-life/


title: appliedclinicaltrialsonline.com: Clinical trials 2026 platformization ai fluency value chain
node_name: FDA Plausible Mechanism Accelerated Approval
created_at: 2026-04-20 20:52:09
url:
https://www.appliedclinicaltrialsonline.com/view/clinical-trials-2026-platformization-ai-fluency-value-chain


title: drugtargetreview.com: How self driving labs are changing drug development
node_name: Self-Driving Lab DMTA Feedback Loop
created_at: 2026-04-20 20:52:09
url:
https://www.drugtargetreview.com/article/193601/how-self-driving-labs-are-changing-drug-development/


title: aidoc.com: Aidoc secures fda clearance for healthcares first comprehensive foundation model ai
node_name: AI Radiology FDA Device Fleet
created_at: 2026-04-20 20:52:09
url:
https://www.aidoc.com/about/news/aidoc-secures-fda-clearance-for-healthcares-first-comprehensive-foundation-model-ai/


title: theimagingwire.com: Ai enabled medical devices granted fda marketing authorization
node_name: AI Radiology FDA Device Fleet
created_at: 2026-04-20 20:52:09
url:
https://theimagingwire.com/2025/12/10/ai-enabled-medical-devices-granted-fda-marketing-authorization/


node_name: Companion Diagnostic CDx Lock-In Mechanism
created_at: 2026-04-20 20:52:09
url:
https://www.foundationmedicine.com/blog/companion-diagnostics-explained-their-critical-role-cancer-care-and-our-latest-approvals

title:
foundationmedicine.com: Companion diagnostics explained their critical role cancer care and our latest approvals


title: globenewswire.com: Global Digital Biomarkers Market to Reach USD 15.60 Billion by 2030
node_name: Digital Biomarker Wearable Clinical Evidence
created_at: 2026-04-20 20:52:09
url:
https://www.globenewswire.com/news-release/2026/03/04/3249443/0/en/Global-Digital-Biomarkers-Market-to-Reach-USD-15.60-Billion-by-2030.html


title: fda.gov: Predetermined change control plans machine learning enabled medical devices
node_name: FDA Predetermined Change Control Plan AI Devices
created_at: 2026-04-20 20:52:09
url:
https://www.fda.gov/medical-devices/software-as-a-medical-device-samd/predetermined-change-control-plans-machine-learning-enabled-medical-devices


node_name: AI Drug Repurposing Knowledge Graph
created_at: 2026-04-20 20:52:09
url:
https://www.drugpatentwatch.com/blog/the-ai-revolution-in-drug-repurposing-a-comprehensive-pipeline-analysis-from-target-identification-to-clinical-and-commercial-validation/

title:
drugpatentwatch.com: The ai revolution in drug repurposing a comprehensive pipeline analysis from target identification to clinical and commercial validation


title: techcommunity.microsoft.com: 4474658
node_name: Ambient AI Clinical Scribe
created_at: 2026-04-20 20:52:09
url:
https://techcommunity.microsoft.com/blog/healthcareandlifesciencesblog/highlights-from-ignite-2025-how-agentic-ai-and-microsoft-copilot-are-empowering-/4474658


node_name: Tempus AI Multimodal Clinical Data Flywheel
created_at: 2026-04-20 20:52:09
url:
https://www.tempus.com/news/tempus-introduces-fuses-a-program-designed-to-transform-therapeutic-research-and-build-the-largest-diagnostic-platform-using-its-novel-foundation-model/

title:
tempus.com: Tempus introduces fuses a program designed to transform therapeutic research and build the largest diagnostic platform using its novel foundation model


node_name: Decentralized Clinical Trial Digital Biomarker Architecture
created_at: 2026-04-20 20:52:09
url:
https://www.ropesgray.com/en/insights/alerts/2026/01/fda-adapts-with-the-times-on-digital-health-updated-guidances-on-general-wellness-products

title:
ropesgray.com: Fda adapts with the times on digital health updated guidances on general wellness products


title: ir.arvinas.com: Arvinas announces fda acceptance new drug application
node_name: PROTAC Targeted Protein Degradation Platform
created_at: 2026-04-20 20:52:09
url:
https://ir.arvinas.com/news-releases/news-release-details/arvinas-announces-fda-acceptance-new-drug-application/


title: iqvia.com: Decentralized trials
node_name: Decentralized Clinical Trial DCT Revolution
created_at: 2026-04-20 20:52:09
url:
https://www.iqvia.com/solutions/research-and-development/patient-and-site-centric-solutions/decentralized-trials


title: aha.org: 2025 10 21 how ai transforming clinical trials
node_name: Decentralized Clinical Trial DCT Revolution
created_at: 2026-04-20 20:52:09
url:
https://www.aha.org/aha-center-health-innovation-market-scan/2025-10-21-how-ai-transforming-clinical-trials


title: fda.gov: Artificial intelligence software medical device
node_name: FDA TPLC AI Medical Device Regulatory Architecture
created_at: 2026-04-20 20:52:09
url:
https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-software-medical-device


title: genengnews.com: Expanding the druggable proteome with tech advances
node_name: AI-Driven Targeted Protein Degradation
created_at: 2026-04-20 20:52:09
url:
https://www.genengnews.com/topics/drug-discovery/expanding-the-druggable-proteome-with-tech-advances/


title: crvscience.com: The code of life how large language models are designing new proteins
node_name: Protein Language Model ESM3 Sequence Design
created_at: 2026-04-20 20:52:09
url:
https://www.crvscience.com/post/the-code-of-life-how-large-language-models-are-designing-new-proteins


title: hoganlovells.com: Fda finalizes realworld evidence guidance for device sponsors
node_name: Real-World Evidence FDA Drug Approval Pathway
created_at: 2026-04-20 20:52:09
url:
https://www.hoganlovells.com/en/publications/fda-finalizes-realworld-evidence-guidance-for-device-sponsors


title: aabb.org: Fda eases access to real world evidence in drug and device reviews
node_name: Real-World Evidence FDA Drug Approval Pathway
created_at: 2026-04-20 20:52:09
url:
https://www.aabb.org/news-resources/news/article/2025/12/16/fda-eases-access-to-real-world-evidence-in-drug-and-device-reviews


node_name: GRAIL Galleri MCED Methylation AI
created_at: 2026-04-20 20:52:09
url:
https://www.prnewswire.com/news-releases/grail-pathfinder-2-results-show-galleri--multi-cancer-early-detection-blood-test-increased-cancer-detection-more-than-seven-fold

title:
prnewswire.com: Grail pathfinder 2 results show galleri multi cancer early detection blood test increased cancer detection more than seven fold


title: appliedclinicaltrialsonline.com: Understanding fda ema guidance ai digital twin applications trials
node_name: Digital Twin Synthetic Control Arm
created_at: 2026-04-20 20:52:09
url:
https://www.appliedclinicaltrialsonline.com/view/understanding-fda-ema-guidance-ai-digital-twin-applications-trials


node_name: Tempus AI Multimodal Oncology Data Flywheel
created_at: 2026-04-20 20:52:09
url:
https://beyondspx.com/quote/TEM/tempus-ai-s-diagnostics-flywheel-why-the-first-adjusted-ebitda-profit-signals-a-decade-of-ai-driven-healthcare-dominance-nasdaq-tem

title:
beyondspx.com: Tempus ai s diagnostics flywheel why the first adjusted ebitda profit signals a decade of ai driven healthcare dominance nasdaq tem


title: investor.nvidia.com: Default
node_name: NVIDIA BioNeMo Drug Discovery Stack
created_at: 2026-04-20 20:52:09
url:
https://investor.nvidia.com/news/press-release-details/2026/NVIDIA-BioNeMo-Platform-Adopted-by-Life-Sciences-Leaders-to-Accelerate-AI-Driven-Drug-Discovery/default.aspx


node_name: Galleri Liquid Biopsy Multi-Cancer Detection
created_at: 2026-04-20 20:52:09
url:
https://www.prnewswire.com/news-releases/grail-pathfinder-2-results-show-galleri-multi-cancer-early-detection-blood-test-increased-cancer-detection-more-than-seven-fold-when-added-to-uspstf-a-and-b-recommended-screenings-302588036.html

title:
prnewswire.com: Grail pathfinder 2 results show galleri multi cancer early detection blood test increased cancer detection more than seven fold when added to uspstf a and b recommended screenings 302588036


title: fda.gov: Artificial intelligence drug development
node_name: FDA AI Credibility Assessment Framework
created_at: 2026-04-20 20:52:09
url:
https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/artificial-intelligence-drug-development


title: fdli.org: Regulating the use of ai in drug development legal challenges and compliance strategies
node_name: FDA AI Credibility Assessment Framework
created_at: 2026-04-20 20:52:09
url:
https://www.fdli.org/2025/07/regulating-the-use-of-ai-in-drug-development-legal-challenges-and-compliance-strategies/


node_name: FDA AI Credibility Assessment Framework
created_at: 2026-04-20 20:52:09
url:
https://www.fda.gov/news-events/press-announcements/fda-proposes-framework-advance-credibility-ai-models-used-drug-and-biological-product-submissions

title:
fda.gov: Fda proposes framework advance credibility ai models used drug and biological product submissions


title: Bloomberg: Tempus transforming care drug discovery with ai
node_name: Tempus AI Integrated Data Flywheel
created_at: 2026-04-20 20:52:09
url:
https://www.bloomberg.com/professional/insights/technology/tempus-transforming-care-drug-discovery-with-ai/


title: thefdalawblog.com: Rwe and ai hand in hand in the future of regulatory decision making
node_name: FDA Real-World Evidence Drug Approval Framework
created_at: 2026-04-20 20:52:09
url:
https://www.thefdalawblog.com/2025/10/rwe-and-ai-hand-in-hand-in-the-future-of-regulatory-decision-making/


node_name: GLP-1 Oncology Anti-Cancer Mechanism
created_at: 2026-04-20 20:52:09
url:
https://www.oncology-central.com/asco-2025-glp-1-agonists-show-potential-in-reducing-obesity-related-cancer-risk/

title:
oncology-central.com: Asco 2025 glp 1 agonists show potential in reducing obesity related cancer risk


title: frontiersin.org
node_name: Autonomous AI Scientist Closed-Loop Discovery
created_at: 2026-04-20 20:52:09
url:
https://www.frontiersin.org/journals/artificial-intelligence/articles/10.3389/frai.2025.1649155/full


node_name: FDA Animal Testing Phase-Out 2025
created_at: 2026-04-20 20:52:09
url:
https://www.biopharmatrend.com/news/fda-shifts-drug-approval-policy-what-does-this-mean-for-ai-enabled-therapies-1501/

title:
biopharmatrend.com: Fda shifts drug approval policy what does this mean for ai enabled therapies 1501


title: raps.org: Ema fda issue joint ai guiding principles for drug
node_name: FDA EMA Good AI Practice Principles 2026
created_at: 2026-04-20 20:52:09
url:
https://www.raps.org/news-and-articles/news-articles/2026/1/ema-fda-issue-joint-ai-guiding-principles-for-drug


title: mcguirewoods.com: Fda and ema provide guiding principles for ai in drug development
node_name: FDA EMA Good AI Practice Principles 2026
created_at: 2026-04-20 20:52:09
url:
https://www.mcguirewoods.com/client-resources/alerts/2026/1/fda-and-ema-provide-guiding-principles-for-ai-in-drug-development/


node_name: FDA EMA Good AI Practice Principles 2026
created_at: 2026-04-20 20:52:09
url:
https://www.appliedclinicaltrialsonline.com/view/fda-ema-align-ten-principles-artificial-intelligence-use-drug-development

title:
appliedclinicaltrialsonline.com: Fda ema align ten principles artificial intelligence use drug development


title: appliedclinicaltrialsonline.com: Fda issues draft guidance advance bayesian methods clinical trials
node_name: AI Adaptive Bayesian Trial Design
created_at: 2026-04-20 20:52:09
url:
https://www.appliedclinicaltrialsonline.com/view/fda-issues-draft-guidance-advance-bayesian-methods-clinical-trials


node_name: AI Adaptive Bayesian Trial Design
created_at: 2026-04-20 20:52:09
url:
https://www.biopharminternational.com/view/how-fda-s-bayesian-guidance-could-accelerate-adaptive-trial-design-in-biopharmaceuticals

title:
biopharminternational.com: How fda s bayesian guidance could accelerate adaptive trial design in biopharmaceuticals


node_name: AI-Designed AAV Capsid Gene Delivery
created_at: 2026-04-20 20:52:09
url:
https://www.biopharminternational.com/view/astellas-licenses-dyno-therapeutics-ai-designed-aav-capsid-advancing-gene-delivery-for-muscle-disorders

title:
biopharminternational.com: Astellas licenses dyno therapeutics ai designed aav capsid advancing gene delivery for muscle disorders


node_name: Multi-Cancer Early Detection MCED Blood Test
created_at: 2026-04-20 20:52:09
url:
https://grail.com/press-releases/grail-announces-positive-top-line-results-from-the-galleri-pathfinder-2-registrational-study/

title:
grail.com: Grail announces positive top line results from the galleri pathfinder 2 registrational study


title: stocktitan.net: Grail submits fda premarket approval application for the galleri tyf9qxl4x87k
node_name: Multi-Cancer Early Detection MCED Blood Test
created_at: 2026-04-20 20:52:09
url:
https://www.stocktitan.net/news/GRAL/grail-submits-fda-premarket-approval-application-for-the-galleri-tyf9qxl4x87k.html


node_name: ctDNA MRD Surrogate Endpoint Clinical Trial Acceleration
created_at: 2026-04-20 20:52:09
url:
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-circulating-tumor-deoxyribonucleic-acid-early-stage-solid-tumor-drug-development-guidance

title:
fda.gov: Use circulating tumor deoxyribonucleic acid early stage solid tumor drug development guidance


node_name: ctDNA MRD Surrogate Endpoint Clinical Trial Acceleration
created_at: 2026-04-20 20:52:09
url:
https://www.federalregister.gov/documents/2026/01/21/2026-01068/minimal-residual-disease-and-complete-response-in-multiple-myeloma-use-as-endpoints-to-support

title:
federalregister.gov: Minimal residual disease and complete response in multiple myeloma use as endpoints to support


node_name: ctDNA MRD Surrogate Endpoint Clinical Trial Acceleration
created_at: 2026-04-20 20:52:09
url:
https://www.onclive.com/view/fda-s-odac-recognizes-mrd-as-an-accepted-end-point-for-accelerated-approval-in-multiple-myeloma

title:
onclive.com: Fda s odac recognizes mrd as an accepted end point for accelerated approval in multiple myeloma


title: investor.lilly.com: Fda approves lillys foundayotm orforglipron only glp 1 pill
node_name: Orforglipron Small-Molecule GLP-1 Disruption
created_at: 2026-04-20 20:52:09
url:
https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill


node_name: Orforglipron Small-Molecule GLP-1 Disruption
created_at: 2026-04-20 20:52:09
url:
https://www.patientcareonline.com/view/fda-approves-orforglipron-first-oral-glp-1-receptor-agonist-for-weight-loss-with-no-food-or-water-restrictions

title:
patientcareonline.com: Fda approves orforglipron first oral glp 1 receptor agonist for weight loss with no food or water restrictions


title: genengnews.com: Pharma bets big on ai platforms with flurry of new year deals
node_name: Pharma Proprietary Biological Data Moat
created_at: 2026-04-20 20:52:09
url:
https://www.genengnews.com/topics/artificial-intelligence/pharma-bets-big-on-ai-platforms-with-flurry-of-new-year-deals/


node_name: AI-Designed Antibody-Drug Conjugates
created_at: 2026-04-20 20:52:09
url:
https://www.debiopharm.com/drug-development/press-releases/debiopharm-forges-ai-powered-alliance-with-nettargets-to-pioneer-dual-payload-adcs-against-drug-resistant-cancers/

title:
debiopharm.com: Debiopharm forges ai powered alliance with nettargets to pioneer dual payload adcs against drug resistant cancers


node_name: AI Biomedical Knowledge Graph Drug Repurposing
created_at: 2026-04-20 20:52:09
url:
https://www.benevolent.com/about-us/publications/expert-augmented-computational-drug-repurposing-identified-baricitinib-treatment-covid-19/

title:
benevolent.com: Expert augmented computational drug repurposing identified baricitinib treatment covid 19


node_name: FDA Ultra-Rare Disease Plausible Mechanism Approval Pathway
created_at: 2026-04-20 20:52:09
url:
https://www.fda.gov/news-events/press-announcements/fda-launches-framework-accelerating-development-individualized-therapies-ultra-rare-diseases

title:
fda.gov: Fda launches framework accelerating development individualized therapies ultra rare diseases


node_name: FDA Ultra-Rare Disease Plausible Mechanism Approval Pathway
created_at: 2026-04-20 20:52:09
url:
https://www.hhs.gov/press-room/fda-launches-framework-accelerating-development-individualized-therapies-ultra-rare-diseases.html

title:
hhs.gov: Fda launches framework accelerating development individualized therapies ultra rare diseases


node_name: FDA Ultra-Rare Disease Plausible Mechanism Approval Pathway
created_at: 2026-04-20 20:52:09
url:
https://alirahealth.com/education-hub/fda-initiatives-and-programs-to-support-development-of-treatments-for-rare-diseases-in-2025/

title:
alirahealth.com: Fda initiatives and programs to support development of treatments for rare diseases in 2025


title: beckershospitalreview.com: What epic is signaling for 2026
node_name: Health Data Moat Competitive Flywheel
created_at: 2026-04-20 20:52:09
url:
https://www.beckershospitalreview.com/healthcare-information-technology/ehrs/what-epic-is-signaling-for-2026/


node_name: AlphaFold3 Diffusion Structure Prediction
created_at: 2026-04-20 20:52:09
url:
https://markets.financialcontent.com/stocks/article/tokenring-2026-2-2-the-biological-singularity-how-alphafold-3-is-rewriting-the-blueprint-of-drug-discovery

title:
markets.financialcontent.com: Tokenring 2026 2 2 the biological singularity how alphafold 3 is rewriting the blueprint of drug discovery


title: fortune.com: Deepmind isomorphic labs cure all diseases ai now first human trials
node_name: Isomorphic Labs IsoDDE Drug Design Engine
created_at: 2026-04-20 20:52:09
url:
https://fortune.com/2025/07/06/deepmind-isomorphic-labs-cure-all-diseases-ai-now-first-human-trials/


node_name: Isomorphic Labs IsoDDE Drug Design Engine
created_at: 2026-04-20 20:52:09
url:
https://trial.medpath.com/news/1684535c55fbeaf9/ai-designed-drug-discovery-reaches-3-billion-milestone-as-isomorphic-labs-partners-with-eli-lilly-and-novartis

title:
trial.medpath.com: Ai designed drug discovery reaches 3 billion milestone as isomorphic labs partners with eli lilly and novartis


node_name: Computational Pathology AI Clinical Grade
created_at: 2026-04-20 20:52:09
url:
https://www.pathai.com/news/pathais-aim-mash-ai-assist-becomes-first-ai-powered-pathology-tool-to-receive-fda-qualification-for-mash-clinical-trials

title:
pathai.com: Pathais aim mash ai assist becomes first ai powered pathology tool to receive fda qualification for mash clinical trials


node_name: GRAIL Galleri MCED Methylation AI Test
created_at: 2026-04-20 20:52:09
url:
https://www.prnewswire.com/news-releases/multi-cancer-early-detection-testing-market-to-reach-us-7-52-billion-by-2033-as-galleri-cancerseek-and-next-gen-liquid-biopsies-lead-global-adoption-302577070.html

title:
prnewswire.com: Multi cancer early detection testing market to reach us 7 52 billion by 2033 as galleri cancerseek and next gen liquid biopsies lead global adoption 302577070


node_name: Recursion OS Phenomics Biological Foundation Model
created_at: 2026-04-20 20:52:09
url:
https://www.researchgate.net/publication/397517709_Leading_AI-Driven_Drug_Discovery_Platforms_2025_Landscape_and_Global_Outlook

title:
researchgate.net: 397517709 Leading AI Driven Drug Discovery Platforms 2025 Landscape and Global Outlook


title: medidata.com: Synthetic control arm
node_name: Synthetic Control Arms Real-World Evidence
created_at: 2026-04-20 20:52:09
url:
https://www.medidata.com/en/clinical-trial-products/medidata-ai/real-world-data/synthetic-control-arm/


title: appliedclinicaltrialsonline.com: 2025 trends leveraging real world data synthetic control arms
node_name: Synthetic Control Arms Real-World Evidence
created_at: 2026-04-20 20:52:09
url:
https://www.appliedclinicaltrialsonline.com/view/2025-trends-leveraging-real-world-data-synthetic-control-arms


node_name: Synthetic Control Arms Real-World Evidence
created_at: 2026-04-20 20:52:09
url:
https://veranahealth.com/how-external-control-arms-and-real-world-data-are-driving-clinical-trial-innovation/

title:
veranahealth.com: How external control arms and real world data are driving clinical trial innovation


title: apheris.com: Aisb network expands federated openfold3 initiative with three new pharma contrib
node_name: Federated Learning Pharma Data Consortium
created_at: 2026-04-20 20:52:09
url:
https://www.apheris.com/resources/blog/aisb-network-expands-federated-openfold3-initiative-with-three-new-pharma-contrib


title: frontiersin.org
node_name: Federated Learning Pharma Data Consortium
created_at: 2026-04-20 20:52:09
url:
https://www.frontiersin.org/journals/drug-safety-and-regulation/articles/10.3389/fdsfr.2025.1579922/full


title: drugtargetreview.com: Ai and the future of biomarker analysis in early rd
node_name: AI Trial Enrichment Patient Stratification Engine
created_at: 2026-04-20 20:52:09
url:
https://www.drugtargetreview.com/article/190428/ai-and-the-future-of-biomarker-analysis-in-early-rd/


title: fda.gov: Fda grand rounds adopting large language models regulatory review 04102025
node_name: FDA Elsa Agentic AI Regulatory Reviewer
created_at: 2026-04-20 20:52:09
url:
https://www.fda.gov/science-research/fda-grand-rounds/fda-grand-rounds-adopting-large-language-models-regulatory-review-04102025


title: frontiersin.org
node_name: AI Pharmacovigilance Real-Time Safety Signal Engine
created_at: 2026-04-20 20:52:09
url:
https://www.frontiersin.org/journals/drug-safety-and-regulation/articles/10.3389/fdsfr.2025.1626822/full


title: pharmuni.com: Signal detection in pharmacovigilance methods steps and types of signals
node_name: AI Pharmacovigilance Real-Time Safety Signal Engine
created_at: 2026-04-20 20:52:09
url:
https://pharmuni.com/2025/11/19/signal-detection-in-pharmacovigilance-methods-steps-and-types-of-signals/


title: appliedclinicaltrialsonline.com: Ai ml real world evidence master protocols trial success
node_name: Master Protocol Platform Trials AI-Enabled
created_at: 2026-04-20 20:52:09
url:
https://www.appliedclinicaltrialsonline.com/view/ai-ml-real-world-evidence-master-protocols-trial-success


